22 related articles for article (PubMed ID: 19540127)
1. Recent Advances in the Phytochemistry of Bryophytes: Distribution, Structures and Biological Activity of Bibenzyl and Bisbibenzyl Compounds.
Sen K; Khan MI; Paul R; Ghoshal U; Asakawa Y
Plants (Basel); 2023 Dec; 12(24):. PubMed ID: 38140499
[TBL] [Abstract][Full Text] [Related]
2. Bis-Bibenzyls from the Liverwort
Ivković I; Novaković M; Veljić M; Mojsin M; Stevanović M; Marin PD; Bukvički D
Plants (Basel); 2021 May; 10(6):. PubMed ID: 34073157
[TBL] [Abstract][Full Text] [Related]
3. Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity.
Nandy S; Dey A
Daru; 2020 Dec; 28(2):701-734. PubMed ID: 32803687
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
5. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
6. Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
Xi GM; Sun B; Jiang HH; Kong F; Yuan HQ; Lou HX
Bioorg Med Chem; 2010 Sep; 18(18):6725-33. PubMed ID: 20724170
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of curcumin mimics with multidrug resistance reversal activities.
Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
[TBL] [Abstract][Full Text] [Related]
8. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
9. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
[TBL] [Abstract][Full Text] [Related]
11. Polyene multi-drug resistance reversal agents.
Andrus MB
Curr Opin Drug Discov Devel; 2004 Nov; 7(6):823-31. PubMed ID: 15595443
[TBL] [Abstract][Full Text] [Related]
12. Chemo-enzymatic transformation of taxanes and their reversal activity towards MDR tumor cells.
Dai J
Curr Top Med Chem; 2009; 9(17):1625-35. PubMed ID: 19903158
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
